Search clinical trials for: CSII, Sitagliptin

Total 911 results

Sun Yat-sen University

Unknown

Effects of Different Early Intensive Therapies on Long-term β-cell Function

Diabetes Mellitus, Type 2
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaborators

Recruiting

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Boehringer Ingelheim

Completed

The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

Germany
AstraZeneca

Completed

Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure (MEASURE-HF)

Heart Failure | Type 2 Diabetes Mellitus

United States, Thailand, Korea, Republic of, Russian Federation, Ukraine, Hungary, Bulgaria, Chile, Canada, Romania
Emory University
Merck Sharp & Dohme LLC

Terminated

DPP-4 Inhibition and TZD for DM Prevention (DInT DM)

Prediabetic State

United States
AstraZeneca
Bristol-Myers Squibb

Completed

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Type 2 Diabetes

Mexico, South Africa, Norway, Argentina, Belgium, Denmark, Sweden, France, Italy
AstraZeneca

Completed

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Type 2 Diabetes

United States, Hungary, Mexico, South Africa, Romania, Poland
Alexandria University

Recruiting

Cognitive Protective Effect of Newer Antidiabetic Drugs

Type 2 Diabetes

Egypt
University of Pavia

Completed

Insulin Pump vs Multiple Daily Injection on Cardiovascular Outcomes (ITALICO) (ITALICO)

Diabetes Mellitus

Italy
Guangdong Provincial People's Hospital

Unknown

Insulin Pump Therapy and Continuous Glucose Monitoring in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

Diabetes | Poor Glycemic Control

China
Brigham and Women's Hospital
Patient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...

Active, not recruiting

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D)

Type2 Diabetes | Renal Disease | Cardiovascular Events

United States
Helse Fonna
Oslo University Hospital; University of Bergen; Haukeland University Hospital; Helse...

Completed

The Impact of Different CSII and CGM Systems on Different Clinical Outcome Variables in Children and Adolescents With Type 1 Diabetes. An Observational Study Form the Norwegian Childhood Diabetes Registry (NCDR)

Diabetes Mellitus, Type 1
University of Sao Paulo General Hospital
InCor Heart Institute

Completed

DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function

Platelet Aggregation During Acute Myocardial Infarction

Brazil
Azienda Ospedaliero-Universitaria Careggi

Completed

Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes

Diabetes Mellitus, Type 1

Italy
Total Child Health, Inc.
Boston Children's Hospital

Active, not recruiting

Online System for Primary Care to Prevent and Address Teen Substance Use (Substance)

Substance Use

United States
Merck Sharp & Dohme LLC

Completed

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University

Unknown

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
University Hospital, Antwerp
Universiteit Antwerpen; York University

Not yet recruiting

cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances (ACT-ONE)

Diabetes Mellitus, Type 1
Sun Yat-sen University

Suspended

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus
Yonsei University

Unknown

Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement

Knee Osteoarthritis

Korea, Republic of
ConSynance Therapeutics

Completed

A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Lin Liao

Unknown

Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin

Type 2 Diabetes Mellitus

China
Sun Yat-sen University

Recruiting

Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease

China
Shanghai Jiao Tong University School of Medicine

Unknown

Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp

Type 2 Diabetes

China
Medical University of Warsaw

Completed

Bolus Calculator and Wireless Communication With Blood Glucose Meter in Management of Type 1 Diabetes Mellitus (T1DM).

Type 1 Diabetes Mellitus

Poland
University of Aarhus

Recruiting

Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis (CSI ProLong)

Leptomeningeal Metastasis

Denmark
The First Affiliated Hospital of Xiamen University

Unknown

Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes

T2DM

China
Federico II University

Completed

OCT and OCT-A Deep Learning in Diabetic Patients Wiht Artificial Pancreas Device

Type 1 Diabetes Mellitus With Artificial Pancreas Device

Italy
Erasmus Medical Center
Ministry of Health

Completed

Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children

Diabetes Mellitus, Type 1 | Child

Netherlands
Sheba Medical Center

Recruiting

Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Israel
Yanbing Li

Recruiting

Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification (ESTIMATOR)

Diabetes type2

China
Lund University

Completed

DPP-4 Inhibition, Incretins and Islet Function (CODI24)

Type 2 Diabetes

Sweden
Korea University Anam Hospital
AstraZeneca

Unknown

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

Diabetes Mellitus, Type II

Korea, Republic of
Boston Children's Hospital
Children's Hospital of Philadelphia; American Academy of Pediatrics

Recruiting

Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care (ASPIRE)

Heavy Drinking | Driving Under the Influence | Riding With Driver Under the Influence

United States
Merck Sharp & Dohme LLC

Completed

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Glucose Intolerance
Sheffield Teaching Hospitals NHS Foundation Trust
King's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (REPOSE)

Type 1 Diabetes

United Kingdom
Bahçeşehir University

Completed

Is Isokinetic Testing an Indicator of Total Knee Arthroplasty

Knee Osteoarthritis

Turkey
Rush University Medical Center
Stanford University

Completed

Telephone Resources and Assistance for Caregivers (TRAC) (TRAC)

Alzheimer's Disease

United States
University of Cambridge
Medical University of Graz

Completed

Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions

Type 1 Diabetes

Austria, United Kingdom
Abbott Medical Devices
Clinical Accelerator

Completed

Cardiovascular Systems Inc. (CSI) pVAD First in Human Study

Coronary Artery Disease

Georgia
University of Pisa

Unknown

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections. (UTI-flog)

Type 2 Diabetes | Urinary Tract Infections

Italy
Baylor College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes

Type 1 Diabetes

United States
Abbott Medical Devices

Withdrawn

CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study

Coronary Artery Disease

Georgia
Steen Andersen
Medtronic

Completed

Effect of CSII and CGM on Progression of Late Diabetic Complications

Type 1 Diabetes Mellitus

Denmark
Sun Yat-sen University

Unknown

Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

Diabetes Mellitus, Type 2
University of Cambridge
Medical University of Graz; Profil Institut für Stoffwechselforschung GmbH

Completed

Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions (AP@home04)

Type 1 Diabetes

United Kingdom, Austria, Germany
University Health Network, Toronto
Merck Sharp & Dohme LLC

Completed

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion (INDORSE)

Type 2 Diabetes

Canada
Serum Institute of India Pvt. Ltd.

Completed

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Poliomyelitis

Bangladesh
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China

3

Subscribe